Phathom Pharmaceuticals to present at investor conferences in September.
PorAinvest
lunes, 25 de agosto de 2025, 8:03 am ET1 min de lectura
PHAT--
At the Cantor Global Healthcare Conference 2025, scheduled for September 3-5, Phathom's management team will participate in one-on-one meetings throughout the conference. The live webcast of the event will be available on the Phathom website. For those unable to attend, the webcast will be archived for up to 90 days following the conclusion of the event [1].
The H.C. Wainwright 27th Annual Global Investment Conference, taking place from September 8-10, will also feature Phathom's management team, who will participate in one-on-one meetings. The live webcast of this event will be available on the Phathom website as well. The webcast will be archived for up to 90 days following the conclusion of the event [1].
Phathom Pharmaceuticals focuses on developing and commercializing novel treatments for gastrointestinal diseases. The company markets VOQUEZNA®, a first-in-class potassium-competitive acid blocker (PCAB) for various gastrointestinal conditions including Non-Erosive GERD and H. pylori infection treatment [1].
References:
[1] https://www.stocktitan.net/news/PHAT/phathom-pharmaceuticals-to-participate-in-upcoming-investor-nnibl7okihup.html
Phathom Pharmaceuticals has announced that management team members will participate in investor conferences in September. The events include the Cantor Global Healthcare Conference 2025 in New York from September 3-5 and the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10. The conferences will feature 1x1 meetings and live webcasts, accessible on the Phathom website.
Phathom Pharmaceuticals (NASDAQ: PHAT) has announced that its management team will participate in two upcoming investor conferences in September 2025. The events include the Cantor Global Healthcare Conference 2025 in New York from September 3-5 and the H.C. Wainwright 27th Annual Global Investment Conference from September 8-10. Both conferences will feature one-on-one meetings and live webcasts, accessible on the Phathom website.At the Cantor Global Healthcare Conference 2025, scheduled for September 3-5, Phathom's management team will participate in one-on-one meetings throughout the conference. The live webcast of the event will be available on the Phathom website. For those unable to attend, the webcast will be archived for up to 90 days following the conclusion of the event [1].
The H.C. Wainwright 27th Annual Global Investment Conference, taking place from September 8-10, will also feature Phathom's management team, who will participate in one-on-one meetings. The live webcast of this event will be available on the Phathom website as well. The webcast will be archived for up to 90 days following the conclusion of the event [1].
Phathom Pharmaceuticals focuses on developing and commercializing novel treatments for gastrointestinal diseases. The company markets VOQUEZNA®, a first-in-class potassium-competitive acid blocker (PCAB) for various gastrointestinal conditions including Non-Erosive GERD and H. pylori infection treatment [1].
References:
[1] https://www.stocktitan.net/news/PHAT/phathom-pharmaceuticals-to-participate-in-upcoming-investor-nnibl7okihup.html
Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema
Comentarios
Aún no hay comentarios